Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight, said John Sharretts, M.D., director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDAs Center for Drug Evaluation and Research
Those Who Have Tried Other Weight Loss Methods : Semaglutide is typically recommended for people who have attempted to lose weight through diet, exercise, or other methods without achieving significant results
Her decision has sometimes felt like a betrayal of her values, but the relief the medication has brought her is undeniable her joint pain has been reduced and the noise around food has been reduced
Their abstract begins: In the SELECT cardiovascular outcomes trial, semaglutide showed a 20% reduction in major adverse cardiovascular events in 17,604 adults with preexisting cardiovascular disease, overw*ight or ob*sity, without diabetes. Already the veracity of the claims in this study is pulled into serious question
